Medical Area
Department of Medicine
Outpatient Clinics Franco Nolè, MD Director
STAFF Senior Deputy Director: Elisabetta Munzone, MD, Maria Giulia Zampino, MD Deputy Directors: Ida Minchella, MD Senior Assistants: Maria Cossu Rocca, MD, Daniela Cullurà, MD Assistants: Gilda Ascione, MD, Gaetano Aurilio, MD, PhD, Simona Blotta, MD, Angela Esposito, MD, Elena Magni, MD, Angela Sciandivasci MD, Elena Verri, MD Data Managers: Laura Adamoli Secretaries: Daniela Bargiggia, Veronica Bruschi, Monica Croce Nurse Coordinator: Alessio Piredda
82
IEO — Scientific Report 2011 — Ongoing research 2012
Activities 2011. The Unit is involved in clinical
research on solid tumors. In particular, the Unit is interested in prospective phase II and III trials addressed to investigate the role of novel anti-cancer drugs, innovative strategies or new therapeutic and tailored approaches with particular interest in Advanced Breast Cancer, Head & Neck Cancer, Gastro-intestinal Tumours, Urogenital Cancer. During 2010, the overall outpatient activities involved more than 8500 treatments in patients with solid tumors The scientific activity is also involved in translational research and research of new prognostic and predictive factors to individualize treatment and to guide therapeutic decisions in clinical practice. The collaboration with clinicians and basic researchers in other departments and divisions of the same institution is encouraged and ensured by regular meetings and discussions in the context of Disease Units tumor-specific. Similarly, the national and international cooperation is supported and the unit participates in and promotes a number of prospective multicenter studies. A specific attention is given to quality of life through the investigation of new strategies such as the “metronomic” administration of continuous low dose chemotherapy in collaboration with basic researchers in order to explore possible antiangiogenic mechanisms of this approach. The ongoing research programs include the evaluation of prognostic and predictive value of circulating tumour cells in advanced and operable breast cancer; in castration resistant and in early stage prostate cancer, in gastrointestinal and head & neck cancer, with the aim to better characterize the behaviour of these disease and to individualize the treatment During 2011, the Unit published 11 research papers, with an overall Impact Factor of 68,881.
IEO — Scientific Report 2011 — Ongoing research 2012
83